Benfotiamine vs Betaine (TMG)

Our assessment

Benfotiamine and Betaine (TMG) serve entirely different biological roles, making them complementary rather than interchangeable. Benfotiamine is a fat-soluble form of vitamin B1 designed to reduce advanced glycation end-products (AGEs). Betaine (TMG) is a methyl donor that reduces homocysteine and supports DNA repair and methylation pathways. Data not available on comparative clinical trials.

How it works

Think of Benfotiamine as a shield against sugar damage — it blocks the formation of AGEs that stiffen tissues and drive diabetic complications. Betaine (TMG), in contrast, acts as a methyl group delivery system — it donates methyl groups to convert homocysteine into methionine, supporting liver function and methylation cycles NIH ODS ↗.

Safety profile

Data not available on adverse event reports for either Benfotiamine or Betaine (TMG). No side effect counts are provided in the FDA data.

Our recommendation

Choose Benfotiamine if your primary concern is blood sugar control or diabetic nerve health, as it targets AGE accumulation. Choose Betaine (TMG) if your priority is cardiovascular risk reduction or liver detoxification support, as it lowers homocysteine. If both apply, they can be used together under professional guidance. Data not available on dosing or interactions.

Benfotiamine may be better if: Glycation reduction: Reduces formation of advanced glycation end-products (AGEs)

Betaine (TMG) may be better if: Homocysteine reduction: Reduces homocysteine via methylation pathways; DNA repair / methylation: Supports DNA repair and methylation pathways